Clinical Trial Update: The Efficacy and Safety of Caffeic Acid for Esophageal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of caffeic acid for esophageal cancer is reported as ongoing with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• caffeic acid

Snippet

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology | Conditions: Esophagus Cancer | Phase 3 | Status: UNKNOWN